EUVIMEDEUVIMED entdecken
Crossref

Novel CAR-T cells targeting TRKB for the treatment of solid cancer

Dandan Liang, Jie Tang, Bin Sun, Shuai He, Dong Yang, Haiyan Ma, Yuncang Yun, Yongjie Zhu, Wenwen Wei, Haiyang Chen, Xudong Zhao

Apoptosis · 2024

DOI: 10.1007/s10495-024-01936-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Apoptosis, 2024. Verfasst von Dandan Liang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Targeting Therapy & Immunology and Laboratory of Animal Tumor Models, Cancer Center and State Key Laboratory of Respiratory Health and …. Hauptthemen laut MEDLINE: Receptor, trkB, Receptors, Chimeric Antigen, Immunotherapy, Adoptive, Brain-Derived Neurotrophic Factor. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimeric antigen receptor (CAR) T-cell therapy is highly effective for treating blood cancers such as B-cell malignancies, however, its effectiveness as an approach to treat solid tumors remains to be further explored. Here, we focused on the development of CAR-T cell therapies targeting tropomyosin-related kinase receptor B (TRKB), a highly expressed protein that is significantly associated with tumor progression, malignancy, and drug resistance in multiple forms of aggressive solid tumors. To achieve this, we screened brain-derived neurotrophic factor (BDNF) and neurotrophin 4 (NTF4) ligand-based CAR-T cells for their efficiency in targeting the TRKB receptor in the context of solid tumors, particularly hepatocellular carcinoma and pancreatic cancer. We demonstrated that TRKB is overexpressed not only in hepatocellular carcinoma and pancreatic carcinoma cell lines but also in cancer stem-like cells (CSCs). Notably, BDNF-CAR T and NTF4-CAR T cells could not only effectively target and kill TRKB-expressing pan-cancer cell lines in a dose-dependent manner but also effectively kill CSCs. We also performed in vivo studies to show that NTF4-CAR T cells have a better potential to inhibit the tumor growth of hepatocellular carcinoma xenografts in mice, compared with BDNF-CAR T cells. Taken together, our findings suggest that CAR-T targeting TRKB may be a promising approach for developing novel therapies to treat solid cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, trkBReceptors, Chimeric AntigenImmunotherapy, AdoptiveBrain-Derived Neurotrophic FactorHumansAnimalsMiceCell Line, TumorXenograft Model Antitumor AssaysCarcinoma, HepatocellularLiver NeoplasmsT-LymphocytesPancreatic NeoplasmsNerve Growth FactorsMembrane GlycoproteinsNeoplasms

Stichwörter der Autor:innen

BDNFCAR-TCancer stem cellsLiver cancerNTF4Pancreatic cancerTRKB

Substanzen

Receptor, trkBReceptors, Chimeric Antigentropomyosin-related kinase-B, humanBrain-Derived Neurotrophic Factorneurotrophin 4Nerve Growth FactorsMembrane GlycoproteinsBDNF protein, human

Autor:innen und Institutionen

  • Department of Targeting Therapy & Immunology and Laboratory of Animal Tumor Models, Cancer Center and State Key Laboratory of Respiratory Health and Multimorbidity and Frontiers Science Center for Disease-related Molecu…
  • Laboratory of Metabolism and Aging Research, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, China. chenhy82@scu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University

Zitieren

APA

Liang, D., Tang, J., Sun, B., He, S., Yang, D., Ma, H., Yun, Y., Zhu, Y., Wei, W., Chen, H., & Zhao, X. (2024). Novel CAR-T cells targeting TRKB for the treatment of solid cancer. Apoptosis. https://doi.org/10.1007/s10495-024-01936-7

Vancouver

Liang D, Tang J, Sun B, He S, Yang D, Ma H, et al. Novel CAR-T cells targeting TRKB for the treatment of solid cancer. Apoptosis. 2024. doi:10.1007/s10495-024-01936-7

BibTeX
@article{Liang2024,
  author = {Liang, Dandan and Tang, Jie and Sun, Bin and He, Shuai and Yang, Dong and Ma, Haiyan and Yun, Yuncang and Zhu, Yongjie and Wei, Wenwen and Chen, Haiyang and Zhao, Xudong},
  title = {Novel CAR-T cells targeting TRKB for the treatment of solid cancer},
  journal = {Apoptosis},
  year = {2024},
  doi = {10.1007/s10495-024-01936-7}
}
Kostenlos starten →